focus -WSS

focus

author：focus 2025-09-30 13:44:22 - browse：4

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

WSS

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Francis Collins on trust in science and how Covid communications failed

My yearlong odyssey to get my son’s ADHD medication covered

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Eli Lilly, Pfizer, and others want in on the online prescription market

ACA's risk program benefits Blue Cross Blue Shield insurers

explore

focus

focus

Moonlake's readout produced a cash windfall. Risks remain

NIH director takes cautious approach to Biden drug pricing priority

DIEP, the 'gold standard' of breast reconstruction, is under threat

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

DIEP, the 'gold standard' of breast reconstruction, is under threat

Pandemic and All Hazards Preparedness Act needs lean update

Affirmative action in medical school literally saved lives

Eli Lilly, Pfizer, and others want in on the online prescription market

Hepatitis C has a cure — but many Americans still lack access to it

Why doctors need education on FDA device approval process

hotspot

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

New brain studies show LSD's effects on the brain in full color

The surgeon had a dilemma only a Nazi medical text could resolve

Test for long Covid? Researchers find new clue in blood samples

Prior authorization will have to move faster under new Biden rule

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

knowledge

hotspot

leisure time

entertainment